Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Validation of the automated method VIENA: An accurate, precise, and robust measure of ventricular enlargement.
Ongoing clinical trials of TYSABRI
Renal deterioration in multiple sclerosis patients with neurovesical dysfunction.
Caruifolin D from artemisia absinthium L. inhibits neuroinflammation via reactive oxygen species-dependent c-jun N-terminal kinase and protein kinase c/NF-κB signaling pathways.
Measuring the Impact of Secondary Progressive Multiple Sclerosis (Spms) in the Ascend Trial: Equating the Msis-29, Msws-12, Abilhand-56 and Sf-36.
Being Kind to Your Future Self: Probability Discounting of Health Decision-Making.
An Individualized Yoga Programme for Multiple Sclerosis: A Case Study.
Chronic cerebrospinal venous insufficiency and multiple sclerosis: a comprehensive meta-analysis of case-control studies.
PSGL-1 and E/P-selectins are essential for T-cell rolling in inflamed CNS microvessels but dispensable for initiation of EAE.
Localisation of citrullinated proteins in normal appearing white matter and lesions in the central nervous system in multiple sclerosis.
Calcium intervention ameliorates experimental model of multiple sclerosis.
Transcription factor induction of human oligodendrocyte progenitor fate and differentiation.
Fostering adherence to injectable disease-modifying therapies in multiple sclerosis.
Stop the silent misdiagnosis: patients' preferences matter.
Is Neuromyelitis Optica with Advanced Age of Onset a Paraneoplastic Disorder?
Down-regulation of Myelin Gene Expression in Human Oligodendrocytes by Nitric Oxide: Implications for Demyelination in Multiple Sclerosis.
Neuronal and axonal loss in normal-appearing gray matter and subpial lesions in multiple sclerosis.
Astrocyte response to IFN-γ limits IL-6-mediated microglia activation and progressive autoimmune encephalomyelitis.
The effect of executive function on stress, depression, anxiety, and quality of life in multiple sclerosis.
Heterogeneous Network Edge Prediction: A Data Integration Approach to Prioritize Disease-Associated Genes.
Lesion filling effect in regional brain volume estimations: a study in multiple sclerosis patients with low lesion load.
[Relationship between the levels and variation of CXCL12, PDGF, CXCL14 in cerebrospinal fluid of optic neuritis and neuromyelitis optica].
Restless legs syndrome associated with major diseases: A systematic review and new concept.
Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial.
Chronic cerebrospinal venous insufficiency is not more prevalent in patients with mild multiple sclerosis: a sonographer-blinded, case-control ultrasound study.
Pages
« first
‹ previous
…
497
498
499
500
501
502
503
504
505
…
next ›
last »